HEALTHCARE RESOURCE UTILIZATION AND ASSOCIATED COSTS IN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) IN ENGLAND: A RETROSPECTIVE OBSERVATIONAL COHORT STUDY

被引：0
|
作者：
Siddiqui, S. [1 ]
Dolin, P. [2 ]
Shavit, A. [2 ]
Rowell, J. [3 ]
Edmonds, C. [4 ]
Kielar, D. [2 ]
Persson, J. [5 ]
Lacetera, A. [6 ]
Suarez-Sanchez, P. [6 ]
Ariti, C. [6 ]
Podmore, B. [6 ]
Velarde, A. Kitchin [6 ]
Chen, S. Y. [7 ]
机构：
[1] Imperial Coll London, Natl Heart & Lung Inst, NIHR Imperial Biomed Res Ctr, London, England
[2] AstraZeneca, BioPharmaceut Med, Cambridge, England
[3] AstraZeneca, Market Access & Pricing, Cambridge, England
[4] AstraZeneca, Market Access & Pricing, Gaithersburg, MD USA
[5] AstraZeneca, Market Access & Pricing, Gothenburg, Sweden
[6] OXONEpidemiology, Madrid, Spain
[7] AstraZeneca, BioPharmaceut Med, Gaithersburg, MD USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE428
引用
收藏
页码：S139 / S140
页数：2
相关论文
共 50 条
  • [1] Treatment patterns for eosinophilic granulomatosis with polyangiitis (EGPA): a retrospective observational cohort study in England
    Siddiqui, Salman
    Dolin, Paul
    Shavit, Anat
    Rowell, Jennifer
    Edmonds, Chris
    Kielar, Danuta
    Lacetera, Alessandra
    Suarez-Sanchez, Pablo
    Ariti, Cono
    Podmore, Belene
    Velarde, Alvaro Kitchin
    Chen, Stephanie
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [2] Mortality in an Eosinophilic Granulomatosis with Polyangiitis ( EGPA) Incident Cohort: A Retrospective Study in England
    Siddiqui, Salman
    Dolin, Paul
    Shavit, Anat
    Rowell, Jennifer
    Edmonds, Chris
    Kielar, Danuta
    Lacetera, Alessandra
    Suarez-Sanchez, Pablo
    Ariti, Cono
    Podmore, Belene
    Kitchin Velarde, Alvaro
    Chen, Stephanie Y.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 154 - 154
  • [3] Disease Overlap, Healthcare Resource Utilization, and Costs in Patients with Eosinophilic Granulomatosis with Polyangiitis: A REVEAL Sub-study
    Xu, Xiao
    Edmonds, Christopher
    Kim, Yongjin
    Stokes, Michael
    Stirnadel-Farrant, Heide A.
    Kwiatek, Justin
    Katial, Rohit
    RHEUMATOLOGY AND THERAPY, 2024, 11 (06) : 1611 - 1628
  • [4] HEALTHCARE UTILISATION OF PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A EUROPEAN PERSPECTIVE
    Jakes, R.
    Kwon, N.
    Huynh, L.
    Hwee, J.
    Baylis, L.
    Alfonso-Cristancho, R.
    Du, S.
    Khanal, N.
    Dun, M. S.
    VALUE IN HEALTH, 2022, 25 (12) : S175 - S175
  • [5] Clinical Manifestations and Health Care Resource Utilization of Eosinophilic Granulomatosis With Polyangiitis (EGPA) in China: A Multicenter Retrospective Cohort Study in China (Interim Analysis)
    Xue, L.
    Tang, Z.
    Cristancho, R. Alfonso
    Jakes, R. W.
    Ahmed, W.
    Fan, L.
    Zhang, Q.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [6] The prevalence, burden of disease, and healthcare utilization of patients with eosinophilic granulomatosis with polyangiitis in Japan: a retrospective, descriptive cohort claims database study
    Sada, Ken-ei
    Kojo, Yoshiki
    Fairburn-Beech, Jolyon
    Sato, Keiko
    Akiyama, Shoko
    Van Dyke, Melissa K.
    Mukai, Isao
    MODERN RHEUMATOLOGY, 2022, 32 (02) : 380 - 386
  • [7] Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study
    Bettiol, Alessandra
    Urban, Maria Letizia
    Bello, Federica
    Fiori, Davide
    Mattioli, Irene
    Lopalco, Giuseppe
    Iannone, Florenzo
    Egan, Allyson
    Dagna, Lorenzo
    Caminati, Marco
    Negrini, Simone
    Bargagli, Elena
    Folci, Marco
    Franceschini, Franco
    Padoan, Roberto
    Flossmann, Oliver
    Solans, Roser
    Schroeder, Jan
    Andre, Marc
    Moi, Laura
    Parronchi, Paola
    Roccatello, Dario
    Sciascia, Savino
    Jayne, David
    Prisco, Domenico
    Vaglio, Augusto
    Emmi, Giacomo
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (12) : 1769 - 1772
  • [8] MEPOLIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A RETROSPECTIVE REAL-WORLD EUROPEAN STUDY ON 142 PATIENTS
    Bettiol, A.
    Urban, M. L.
    Alberici, F.
    Agostini, C.
    Baldini, C.
    Bozzolo, E.
    Cameli, P.
    Crimi, N.
    Del Giacco, S.
    Egan, A.
    Espigol-Frigole, G.
    Felicetti, M.
    Folci, M.
    Fraticelli, P.
    Govoni, M.
    Kernder, A.
    Lombardi, C.
    Lopalco, G.
    Lunardi, C.
    Mohammad, A. J.
    Moosig, F.
    Negrini, S.
    Neumann, T.
    Novikov, P.
    Paolazzi, G.
    Parronchi, P.
    Quartuccio, L.
    Racanelli, V.
    Salvarani, C.
    Samson, M.
    Schroeder, J.
    Sciascia, S.
    Sinico, R. A.
    Terrier, B.
    Toniati, P.
    Prisco, D.
    Vaglio, A.
    Emmi, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 94 - 95
  • [9] Healthcare resource utilization and costs in patients with eosinophilic granulomatosis with polyangiitis versus severe uncontrolled asthma: a retrospective analysis of US health insurance claims data
    Dolin, Paul
    Kielar, Danuta
    Shavit, Anat
    Keogh, Karina
    Rowell, Jennifer
    Edmonds, Chris
    Meyers, Juliana
    Esterberg, Elizabeth
    Nham, Tram
    Chen, Stephanie
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB206 - AB206
  • [10] PREVALENCE, BURDEN OF DISEASE AND HEALTHCARE UTILIZATION AMONG PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) IN JAPAN 2005-2017
    Sada, K. E.
    Kojo, Y.
    Fairburn-Beech, J.
    Sato, K.
    Hayashi, E.
    Akiyama, S.
    Van-Dyke, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 688 - 689
12345